Cargando…

Biopsy proven acute interstitial nephritis after treatment with moxifloxacin

BACKGROUND: Acute interstitial nephritis (AIN) is an important cause of reversible acute kidney injury. At least 70% of AIN is caused by various drugs, mainly penicillines and non-steroidal anti-inflammatory drugs. Quinolones are only rarely known to cause AIN and so far cases have been mainly descr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatzikyrkou, Christos, Hamwi, Iyas, Clajus, Christian, Becker, Jan, Hafer, Carsten, Kielstein, Jan T
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936368/
https://www.ncbi.nlm.nih.gov/pubmed/20731847
http://dx.doi.org/10.1186/1471-2369-11-19
_version_ 1782186479409168384
author Chatzikyrkou, Christos
Hamwi, Iyas
Clajus, Christian
Becker, Jan
Hafer, Carsten
Kielstein, Jan T
author_facet Chatzikyrkou, Christos
Hamwi, Iyas
Clajus, Christian
Becker, Jan
Hafer, Carsten
Kielstein, Jan T
author_sort Chatzikyrkou, Christos
collection PubMed
description BACKGROUND: Acute interstitial nephritis (AIN) is an important cause of reversible acute kidney injury. At least 70% of AIN is caused by various drugs, mainly penicillines and non-steroidal anti-inflammatory drugs. Quinolones are only rarely known to cause AIN and so far cases have been mainly described with older fluoroquinolones. CASE PRESENTATION: Here we describe a case of biopsy proven interstitial nephritis after moxifloxacin treatment. The patient presented with fever, rigors and dialysis dependent acute kidney injury, just a few days after treatment of a respiratory tract infection with moxifloxacin. The renal biopsy revealed dense infiltrates mainly composed of eosinophils and severe interstitial edema. A course of oral prednisolone (1 mg/kg/day) was commenced and rapidly tapered to zero within three weeks. The renal function improved, and the patient was discharged with a creatinine of 107 μmol/l. CONCLUSION: This case illustrates that pharmacovigilance is important to early detect rare side effects, such as AIN, even in drugs with a favourable risk/benefit ratio such as moxifloxacin.
format Text
id pubmed-2936368
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29363682010-09-10 Biopsy proven acute interstitial nephritis after treatment with moxifloxacin Chatzikyrkou, Christos Hamwi, Iyas Clajus, Christian Becker, Jan Hafer, Carsten Kielstein, Jan T BMC Nephrol Case Report BACKGROUND: Acute interstitial nephritis (AIN) is an important cause of reversible acute kidney injury. At least 70% of AIN is caused by various drugs, mainly penicillines and non-steroidal anti-inflammatory drugs. Quinolones are only rarely known to cause AIN and so far cases have been mainly described with older fluoroquinolones. CASE PRESENTATION: Here we describe a case of biopsy proven interstitial nephritis after moxifloxacin treatment. The patient presented with fever, rigors and dialysis dependent acute kidney injury, just a few days after treatment of a respiratory tract infection with moxifloxacin. The renal biopsy revealed dense infiltrates mainly composed of eosinophils and severe interstitial edema. A course of oral prednisolone (1 mg/kg/day) was commenced and rapidly tapered to zero within three weeks. The renal function improved, and the patient was discharged with a creatinine of 107 μmol/l. CONCLUSION: This case illustrates that pharmacovigilance is important to early detect rare side effects, such as AIN, even in drugs with a favourable risk/benefit ratio such as moxifloxacin. BioMed Central 2010-08-23 /pmc/articles/PMC2936368/ /pubmed/20731847 http://dx.doi.org/10.1186/1471-2369-11-19 Text en Copyright ©2010 Chatzikyrkou et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Chatzikyrkou, Christos
Hamwi, Iyas
Clajus, Christian
Becker, Jan
Hafer, Carsten
Kielstein, Jan T
Biopsy proven acute interstitial nephritis after treatment with moxifloxacin
title Biopsy proven acute interstitial nephritis after treatment with moxifloxacin
title_full Biopsy proven acute interstitial nephritis after treatment with moxifloxacin
title_fullStr Biopsy proven acute interstitial nephritis after treatment with moxifloxacin
title_full_unstemmed Biopsy proven acute interstitial nephritis after treatment with moxifloxacin
title_short Biopsy proven acute interstitial nephritis after treatment with moxifloxacin
title_sort biopsy proven acute interstitial nephritis after treatment with moxifloxacin
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936368/
https://www.ncbi.nlm.nih.gov/pubmed/20731847
http://dx.doi.org/10.1186/1471-2369-11-19
work_keys_str_mv AT chatzikyrkouchristos biopsyprovenacuteinterstitialnephritisaftertreatmentwithmoxifloxacin
AT hamwiiyas biopsyprovenacuteinterstitialnephritisaftertreatmentwithmoxifloxacin
AT clajuschristian biopsyprovenacuteinterstitialnephritisaftertreatmentwithmoxifloxacin
AT beckerjan biopsyprovenacuteinterstitialnephritisaftertreatmentwithmoxifloxacin
AT hafercarsten biopsyprovenacuteinterstitialnephritisaftertreatmentwithmoxifloxacin
AT kielsteinjant biopsyprovenacuteinterstitialnephritisaftertreatmentwithmoxifloxacin